The Manila Times

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE ...

Agios Pharmaceuticals, Inc.: U.S. FDA Grants Priority Review to Agios' sNDA for Mitapivat in Sickle Cell Disease

FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Goldseiten

Rare Earths Americas Identifies Large Rare Earth-Niobium Alkaline-Carbonatite System; Discovery Model Strengthens as 15,000m Drill Program Gets Underway at Homer

Rare Earths Americas, Inc. , today announced exploration results that strengthen the Company's geological discovery model at its 100%-owned Homer-A project in Brazil's Goiás Alkaline Province .

Fredonia Provides El Dorado Monserrat Project and Corporate Update

Fredonia Mining Inc. ("Fredonia" or the "Company") (TSXV: FRED) is pleased to provide an update on the continued advancement of its flagship El ...
EC&M

Seven Practical Tips for Optimizing Labor

He also has extensive knowledge of, and practical expertise with, the National Electrical Code (NEC). Through his consulting ...